Dr Lal PathLabs adds genomics heft with SN Genelab deal
New Delhi, Sept. 28 -- Dr Lal PathLabs is buying 70% of SN Genelab for Rs.168 crore. There's also an additional Rs.31.5 crore it will pay if SN Genelab hits certain performance targets.SN Genelab's fiscal year (FY26) revenue was Rs.58 crore, which is just 2% of Dr Lal's revenue last year. So, an im…